Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Laryngitis
ADR ID BADD_A02486
ADR Hierarchy
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.13      Upper respiratory tract infections
11.01.13.001      Laryngitis
22      Respiratory, thoracic and mediastinal disorders
22.07      Respiratory tract infections
22.07.03      Upper respiratory tract infections NEC
22.07.03.001      Laryngitis
Description A disorder characterized by an inflammatory process involving the larynx. [CTCAE] Inflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS. [MeSH]
MedDRA Code 10023874
MeSH ID D007827
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute laryngitis | Chronic laryngitis | Laryngitis | Laryngitis (acute) | Laryngitis acute NOS | Laryngitis chronic | Laryngitis chronic NOS | Laryngitis NOS | Infective laryngitis | Laryngitides
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02346Venlafaxine--
BADD_D02367Voltaren--
BADD_D02379Zaleplon--
BADD_D02393Zolmitriptan--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02431Colesevelam0.001221%
BADD_D02464Fingolimod0.011580%
BADD_D02510Rucaparib0.001066%
The 6th Page    First    Pre   6    Total 6 Pages